Cannabinoid receptor mediating compounds

US11155521B2 · kind B2 · utility

Assignee

• The United States of America, as represented by the Secretary, Department of Health and Human Services · US

Inventors

• Resat Cinar · Bethesda, US
• George Kunos · Bethesda, US
• Malliga Iyer · Germantown, US
• William A. Gahl · Kensington, US
• Bernadette R. Gochuico · Potomac, US
• May C. Malicdan · Rockville, US

Key dates

• Filing date: Mar 4, 2016
• Grant date: Oct 26, 2021
• Expiry date: Mar 4, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D403/12
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CB1 receptor mediating scaffold and (ii) a second therapeutic scaffold.